News About: R&D


Domestic drug companies rush in Cisapride development.

Local drug companies rushed in a market search of Cisapride (Brand name: Prepulcid), a gastric motility enhancer, originally developed by Janssen, who has enjoyed the market with this product since long time but now e...

Stock prices of pharmaceutical industry sensitively moved by new drug development.

Overall stock prices of pharmaceutical industries last year showed an ultimate bipolar phenomenon in the bourse with a great wave of fluctuation, manifesting comparatively higher figures with the R&D oriented pharmace...

Law pertaining to new drug R&D promotion from natural resources.

The National Assembly enacted the law pertaining to new drug R&D promotion from natural resources to make a bridgehead for advancing the domestic drug industry in the 21st century. The law jointly raised by 13 ruling...

Revised criteria on drug revaluation announced to be legislated

The KFDA announced to legislate "Revised bill for drug revaluation standard" on Nov. 12 for the purpose of supplementing problems and shortcomings as resulted from revaluation and examination of the product on subject...

Uniformity in number of patients for clinical test to be modified.

The new drug re-evaluation system implemented from 1995 has to be reasonably readjusted in its provisional requirement of tested patient numbers that should be varied by different preparations in consideration with ea...

Development of intermediary compounds for 4th generation antibiotics in progress.

Daewoong Chemical (President: Mr. Moon Soon-ku) has succeeded in developing the key intermediary compounds (DW-1150) for the new 4th generation of Phenem and Carbaphenem antibiotics, The core technology of the i...

1,500 billion won subsidy for new drug R&D by 2010.

The MOHW announced in the meeting of the parliamentary inspection of the government administration that 1,500 billion won of financial subsidy would be provided for the R&D of new drug discovery by year 2010 especial...

Investment efficiency of new drug R&D enhanced by out-sourcing

The commercialization of the first domestic new drug strongly motivated local pharmaceutical industry to seek enhancement of efficiency in new drug R&D investment by means of utilizing the third party resource in thei...

Foreigner's drug community seeks government special privilege on new drugs.

The foreign pharmaceutical corporations made a strategic approach to our government through an international diplomatic channel and American PMA for the future new drugs to get the price approval at a higher level tha...

Domestic and foreign drug firms on patent dispute.

As domestic firms are developing new drugs that could be manufactured by their patented process developed by their own research and technology resulting from the R&D progress through long time investment for their res...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.